Medican Enterprises, Inc.
Medican Enterprises, Inc. (MDCN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdcn · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medican Enterprises, Inc. (MDCN) measures how much investors pay for each dollar of the company's trailing earnings. MDCN's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2001 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%0.0x
MedianQ3 · 75%5.8x
Max
At N/A, MDCN's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Real Estate - Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medican Enterprises, Inc.You MDCN | $3M | N/A | — | -$0.00 |
 Broad Street Realty, Inc. BRST | $0M | N/A | — | -$0.29 |
 Carnegie Development, Inc. CDJM | $0M | N/A | — | -$0.00 |
 Community Redevelopment Inc. CRDV | $0M | N/A | — | -$0.00 |
 ECC Capital Corporation ECRO | $2M | 6.87x | — | $0.02 |
 Encounter Development Technologies Inc. ENTI | $0M | N/A | — | -$0.03 |
 FutureLand, Corp. FUTL | $1M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.00 | — | |
2023-12-31 FY2023 | 5.77x | $0.00 | +940499.5% | |
2022-12-31 FY2022 | 0.00x | $0.00 | -98.8% | |
2021-12-31 FY2021 | 0.05x | $0.00 | +19347.9% | |
2020-12-31 FY2020 | 0.00x | $0.00 | -96.9% | |
2019-12-31 FY2019 | 0.01x | $0.00 | — | |
2014-12-31 FY2014 | — | $-0.01 | — | |
2013-12-31 FY2013 | — | $-0.00 | — | |
2012-12-31 FY2012 | — | $-0.00 | — | |
2011-12-31 FY2011 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medican Enterprises, Inc. (MDCN) measures how much investors pay for each dollar of the company's trailing earnings. MDCN's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
MDCN pe ratio · 6 questionsMDCN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via MDCN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medican Enterprises, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09